Difference between revisions of "Medication Data"

From SICDB Doc
Jump to navigation Jump to search
(Created page with "== Data Description == The medication table contains data == Predefined Fields (RoDataServer) == == Known Limitations == The medication data is generally considered as being widely valid. Nevertheless there are some limitations to be stated: === Offsets and Times === The offset is the documented time of drug application. As the observed intensive care unity do not use perfusor telemetry all values are entered manually. Following inaccuracies of of time give may be...")
 
Line 18: Line 18:


The difference is explained in different default view range in medication input forms.
The difference is explained in different default view range in medication input forms.
=== Different Reference for similar drugs ===
Due to liberal laws concerning drug names in Austria not all drugs are correctly labeled by their INN name and sometimes multiple proprietary products for the same substance are used. The SICDB Team used an algorithm to identify and unify the medication data. There may be special cases where this procedure failed, for example at compound antihypertensive drugs.

Revision as of 10:26, 1 February 2022

Data Description

The medication table contains data

Predefined Fields (RoDataServer)

Known Limitations

The medication data is generally considered as being widely valid. Nevertheless there are some limitations to be stated:

Offsets and Times

The offset is the documented time of drug application. As the observed intensive care unity do not use perfusor telemetry all values are entered manually. Following inaccuracies of of time give may be generally expected:

  • +/- 5 minutes in anaesthesia settings
  • +/- 5 minutes in resuscitation settings
  • +/- 15 minutes in intensive care settings

The difference is explained in different default view range in medication input forms.

Different Reference for similar drugs

Due to liberal laws concerning drug names in Austria not all drugs are correctly labeled by their INN name and sometimes multiple proprietary products for the same substance are used. The SICDB Team used an algorithm to identify and unify the medication data. There may be special cases where this procedure failed, for example at compound antihypertensive drugs.